Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 58

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 58
---
 the ESPP were increased by 3,177,992 and 440,502, respectively, pursuant to the automatic increase provisions of such plans. |

| (2) | The weighted average exercise price is calculated based solely on outstanding stock options. It does not take into account the shares of our Class A common stock underlying RSUs, which have no exercise price. |

| (3) | Consists of shares available for future issuance under the 2021 Plan and the ESPP. As of December 31, 2024, 682,278 shares of our Class A common stock were available for issuance under the 2021 Plan, and 1,059,692 shares of our Class A common stock were available for issuance under the ESPP. |

| (4) | Consists of the Inducement Plan. On February 3, 2024, the Company initially reserved 500,000 shares of our Class A common stock for issuance under the Inducement Plan. On August 28, 2024, the Company reserved an additional 750,000 shares of our Class A common stock for issuance under the Inducement Plan. |

| (5) | Consists of shares available for future issuance under the Inducement Plan. As of December 31, 2024, 71,075 shares of our Class A common stock were available for issuance under the Inducement Plan. |

Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has generally granted new-hire option awards to executive officers on or around the date of appointment of such executive officers, and all other new-hire option awards have typically been granted the first week of the month following such new hire’s employment start date. Annual refresh employee option grants are typically made in the first quarter of each fiscal year, which refresh grants are typically approved at the regularly scheduled meeting of the Compensation Committee occurring in such quarter. Also, non-employee directors receive automatic grants of initial and annual stock option awards, at the time of a director’s initial appointment or election to the board and at the time of each annual meeting of the Company’s stockholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under the heading, “Director Compensation”below. The Company does not otherwise maintain any written policies on the timing of awards of stock